Extracts of the geranium plant Pelargonium sidoides
inactivate human immunodeficiency virus type 1 (HIV-1) and prevent the virus
from invading human cells. In the current issue of "PLOS ONE”, scientists
from the Helmholtz Zentrum München report that these extracts represent a
potential new class of anti-HIV-1 agents for the treatment of AIDS.